Irinotecan Hydrochloride — 40MG, Injection, 1 × 2 mL vial

Irinotecan Hydrochloride — 40MG, Injection, 1 × 2 mL vial

Irinotecan Hydrochloride is a injection for intravenous use. Irinotecan Hydrochloride Injection, USP is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy. Irinotecan Hydrochloride Injection, USP is a topoisomerase inhibitor indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy.

• Active ingredient or product type: IRINOTECAN HYDROCHLORIDE
• Strength/concentration: 40MG
• Dosage form and route: Injection, Intravenous
• Exact package presentation: 1 × 2 mL vial
• NDC/item number: 0143-9702-01
• Manufacturer: HIKMA PHARMACEUTICALS USA INC
• Storage/handling: Store at 20° to 25° C (68° to 77° F). Protect from light. Protect from freezing.
• Status: Rx only

Important safety information: Diarrhea and cholinergic reactions : Early diarrhea (occurring during or shortly after infusion of irinotecan hydrochloride injection) is usually transient and may be accompanied by cholinergic symptoms.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.